Trial: 201710206

Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair

Phase

III

Principal Investigator

Pedersen, Katrina

Disease Site

Colon

Learn more about this study at: clinicaltrials.gov